CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Option exercise President & CEO acquired 10,000 shares (option exercise)
- 8-K Event Executive or director change
- 4 Open-market sale President and CEO sold 16,700 shares at an average $68.49 ($1,143,860)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $74.34 ($549,173)
- 4 Option exercise Chief Financial Officer acquired 6,128 shares (option exercise)
- 4 Option exercise President & CEO acquired 10,000 shares (option exercise)
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 20,000 shares at $76.00 ($1,520,000)
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
Page 18 of 22 · 421 filings